Novel Corona virus (COVID-19)
A contagious disease which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is Coronavirus disease 2019.The disease was first spotted in December of 2019 in Wuhan, China, and has spread all over, resulting in 2019–20 coronavirus pandemic. A group of related viruses that cause diseases in mammals and birds are Coronaviruses. It causes respiratory tract infections that can range from mild to lethal in humans. Mild illnesses build some cases of the common cold, while more lethal varieties can cause SARS, MERS, and COVID19.
- Transmission
- Virology
- Pathophysiology
- Immunopathology
Related Conference of Novel Corona virus (COVID-19)
October 24-25, 2024
4th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Paris, France
Novel Corona virus (COVID-19) Conference Speakers
Recommended Sessions
- Asthma and Allergy
- Bronchial Disorders
- Cardio Pulmonary Disorders
- Chronic Obstructive Pulmonary Disease (COPD)
- Interstitial Lung Disease
- Lung Cancer
- Lung Transplantation
- Novel Corona virus (COVID-19)
- Pandemic Flu
- Pediatric Pulmonology & Critical Care
- Pleural Diseases
- Pneumonia
- Prevention and Control of Respiratory Diseases
- Pulmonary Rehabilitation
- Respiratory Equipment Devices
Related Journals
Are you interested in
- Advancements in Pulmonary Diagnostics - Respiratory 2024 (France)
- Asthma - Tuberculosis-2024 (France)
- Atelectasis and Pneumothorax - Tuberculosis-2024 (France)
- Cardio Pulmonary Disorders - Respiratory 2024 (France)
- Cardiopulmonary Disease - Tuberculosis-2024 (France)
- Chronic Obstructive Pulmonary Disease - Respiratory 2024 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2024 (France)
- Climate Change and Respiratory Diseases - Tuberculosis-2024 (France)
- COVID-19 and Asthma - Respiratory 2024 (France)
- COVID-19 and Respiratory System - Respiratory 2024 (France)
- Epidemiology of TB Disease - Tuberculosis-2024 (France)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2024 (France)
- Idiopathic Pulmonary Fibrosis - Respiratory 2024 (France)
- Interstitial Lung Disease - Respiratory 2024 (France)
- Latent TB Infection and Active TB Disease - Tuberculosis-2024 (France)
- Lung Cancer - Respiratory 2024 (France)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2024 (France)
- Lung Function in Men with and without HIV - Tuberculosis-2024 (France)
- Lung Infection - Tuberculosis-2024 (France)
- Lung Transplantation - Respiratory 2024 (France)
- Multidrug-resistant TB - Tuberculosis-2024 (France)
- Mycobacterial Infections - Tuberculosis-2024 (France)
- Obstructive Sleep Apnea - Respiratory 2024 (France)
- Occupational Lung Diseases - Respiratory 2024 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2024 (France)
- Pneumonia - Respiratory 2024 (France)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2024 (France)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2024 (France)
- Pulmonary diseases: Treatment, Diagnosis and therapies - Respiratory 2024 (France)
- Pulmonary Edema - Tuberculosis-2024 (France)
- Pulmonary Hypertension - Respiratory 2024 (France)
- Pulmonary Rehabilitation - Respiratory 2024 (France)
- TB Clinical Trials - Tuberculosis-2024 (France)
- TB Diagnosis, Prevention & Treatment - Tuberculosis-2024 (France)
- TB Vaccines - Tuberculosis-2024 (France)
- TB-HIV Co-infections - Tuberculosis-2024 (France)
- Tuberculosis - Respiratory 2024 (France)
- Zoonotic TB - Tuberculosis-2024 (France)